Systematic review of artificial intelligence for personalized oral anticoagulation management in cardiovascular care
Year: 2026
Type: preprint
Study design: Systematic Review
Abstract: Artificial intelligence and machine learning are increasingly used to personalize oral anticoagulation. We systematically reviewed patient-level studies in adults actively receiving warfarin, vitamin K antagonists, or direct oral anticoagulants. PubMed, Europe PMC, and Scopus were searched from inception to 15 August 2026. Of 984 records, 54 studies met eligibility criteria after duplicate removal, title and abstract screening, and full-text assessment. Applications included dose optimization and anticoagulation control, prediction of bleeding and thromboembolic outcomes, and individualized treatment selection. Warfarin dominated dose-optimization research, whereas direct oral anticoagulants were more prominent in risk and comparative-treatment modelling. Across the evidence base, limited external validation, inconsistent calibration, and sparse prospective evaluation restricted clinical translation. AI-enabled anticoagulation is progressing from static prediction toward longitudinal and treatment-specific decision support, but robust multicentre validation remains essential.
Source: Research Square
Institutions: University of Cyberjaya, Hospital Kuala Lumpur
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: artificial intelligence, personalized anticoagulation, oral anticoagulants, warfarin, vitamin K antagonists, direct oral anticoagulants, dose optimization, anticoagulation management, bleeding risk prediction, treatment selection, clinical decision support, external validation, cardiovascular care
Open Access status: green
OpenAlex ID: W7236107082
